Free Trial

Bridgewater Associates LP Purchases 185,779 Shares of Genpact Limited (NYSE:G)

Genpact logo with Business Services background

Bridgewater Associates LP increased its position in Genpact Limited (NYSE:G - Free Report) by 241.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 262,600 shares of the business services provider's stock after acquiring an additional 185,779 shares during the quarter. Bridgewater Associates LP owned about 0.15% of Genpact worth $11,279,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. HighTower Advisors LLC bought a new stake in shares of Genpact during the 3rd quarter valued at $232,000. Stifel Financial Corp bought a new stake in shares of Genpact during the third quarter valued at about $1,197,000. Orion Portfolio Solutions LLC bought a new position in shares of Genpact in the third quarter valued at approximately $211,000. MML Investors Services LLC grew its stake in Genpact by 31.4% during the third quarter. MML Investors Services LLC now owns 12,058 shares of the business services provider's stock valued at $473,000 after acquiring an additional 2,879 shares in the last quarter. Finally, M&T Bank Corp bought a new stake in Genpact during the 3rd quarter worth approximately $206,000. 96.03% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the sale, the chief executive officer now owns 310,246 shares of the company's stock, valued at $15,167,926.94. This trade represents a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 2.80% of the company's stock.

Genpact Trading Up 1.4 %

NYSE:G traded up $0.67 during trading hours on Tuesday, reaching $47.35. The company's stock had a trading volume of 80,283 shares, compared to its average volume of 1,340,741. The firm has a 50-day simple moving average of $50.36 and a 200-day simple moving average of $46.18. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. Genpact Limited has a 1 year low of $30.38 and a 1 year high of $56.76. The firm has a market capitalization of $8.32 billion, a price-to-earnings ratio of 16.68, a PEG ratio of 1.84 and a beta of 1.06.

Genpact (NYSE:G - Get Free Report) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. Research analysts expect that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were given a dividend of $0.17 per share. The ex-dividend date of this dividend was Tuesday, March 11th. This represents a $0.68 annualized dividend and a yield of 1.44%. This is a boost from Genpact's previous quarterly dividend of $0.15. Genpact's dividend payout ratio is presently 23.94%.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on G shares. Needham & Company LLC upped their price target on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and lifted their price target for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Mizuho upped their price objective on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research report on Monday, February 10th. Finally, TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and raised their target price for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Six equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $48.44.

Check Out Our Latest Analysis on Genpact

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up
Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines